Abstract

HaemophiliaVolume 15, Issue 2 p. 637-637 Free Access Errata This article corrects the following: INTRODUCTORY NOTE J. OLDENBURG, S. ZUPANČIĆ ŠALEK, Volume 15Issue s1Haemophilia pages: 1-1 First Published online: December 24, 2008 First published: 23 March 2009 https://doi.org/10.1111/j.1365-2516.2009.02014_2.xAboutSectionsPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat In Oldenberg and ZupančićŠalek [2], the ‘Conflict of Interest’ statement was omitted from the article. The statement should read: J. Oldenburg has acted as a paid consultant and/or speaker (including symposia) for Bayer, Baxter, Biotest, Biovitrum, CLS Behring, NovoNordisk, Octapharma and Wyeth and has received funds for research from Baxter and NovoNordisk. Silva ZupančićŠalek has acted as a paid consultant and/or speaker (including symposia) for Bayer, Baxter and NovoNordisk. References 1 Den Uijl IEM, Fischer K, Van Der Bom JG, Grobbee DE, Rosendaal FR, Plug I. Clinical outcome of moderate haemophilia compared with severe and mild haemophilia. Haemophilia 2009; 15: 83– 90. Wiley Online LibraryCASPubMedWeb of Science®Google Scholar 2 Oldenberg J, ZupančićŠalek S. Introduction. Haemophilia 2009; 15(Suppl. 1): 1. Wiley Online LibraryWeb of Science®Google Scholar 3 Iorio A, Oliovecchio E, Morfini M, Mannucci PM. Italian Registry of Haemophilia and Allied Disorders. Objectives, methodology and data analysis. Haemophilia 2008; 14: 444– 53. Wiley Online LibraryCASPubMedWeb of Science®Google Scholar Volume15, Issue2March 2009Pages 637-637 ReferencesRelatedInformation

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call